findmyKOL
Clinical trialNCT01012375CompletedPhase 2Interventional

Study to Investigate the Efficacy and Tolerability of AZD1446 in Adult ADHD Patients.

SponsorAstraZenecaEnrollment135Adult ADHD
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Research Site

    Los Alamitos, California, United States

  • Research Site

    Fort Myers, Florida, United States

  • Research Site

    New York, New York, United States

  • Research Site

    Austin, Texas, United States

  • Research Site

    Burlington, Vermont, United States

  • Research Site

    Seattle, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Nov 2009
Primary completion
31 Aug 2010
Completion
31 Aug 2010
Last update posted
2 Sept 2011
Registered enrollment
135
Registry id
NCT01012375

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.